Exact Mass: 500.135

Nocardicin A

C23H24N4O9 (500.1543)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

(S)-N-[3-(3,4-Methylenedioxyphenyl)-2-(acetylthio)methyl-1-oxoprolyl]-(S)-alanine benzyl ester

C25H28N2O7S (500.1617)

1843U89

C27H24N4O6 (500.1696)

Nocardicin B

C23H24N4O9 (500.1543)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

Fluticasone propionate

C25H31F3O5S (500.1844)

Fluticasone propionate, a medium-potency synthetic corticosteroid, is used topically to relieve inflammatory and pruritic symptoms of dermatoses and psoriasis, intranasally to manage symptoms of allergic and non-allergic rhinitis, and orally for the treatment of asthma. Fluticasone propionate binds to the glucocorticoid receptor. Unbound corticosteroids cross the membranes of cells such as mast cells and eosinophils, binding with high affinity to glucocorticoid receptors (GR). The results include alteration of transcription and protein synthesis, a decreased release of leukocytic acid hydrolases, reduction in fibroblast proliferation, prevention of macrophage accumulation at inflamed sites, reduction of collagen deposition, interference with leukocyte adhesion to the capillary wall, reduction of capillary membrane permeability and subsequent edema, reduction of complement components, inhibition of histamine and kinin release, and interference with the formation of scar tissue. In the management of asthma, the glucocorticoid receptor complexes down-regulates proinflammatory mediators such as interleukin-(IL)-1, 3, and 5, and up-regulates anti-inflammatory mediators such as IκB (inhibits NF-κB). Corticosteroids are the most effective anti-inflammatory therapy for allergic diseases. They are believed to inhibit T helper cell type 2 (TH2 T-cell) activation through increased immunoregulatory T cell (CD4+CD25+) suppression (PMID: 15316506). Fluticasone propionate is marketed under the brand name Flixotide and Flixonase by Allen & Hanburys, and Flovent and Flonase by GlaxoSmithKline. Fluticasone propionate is only found in individuals that have used or taken this drug. Hanburys and Flovent and Flonase by GlaxoSmithKline.; Fluticasone propionate is a potent glucocorticoid often prescribed as treatment for asthma and allergic rhinitis. It is marketed with the brand name Flixotide and Flixonase by Allen & Fluticasone is a potent glucocorticoid often prescribed as treatment for asthma and allergic rhinitis. D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D000893 - Anti-Inflammatory Agents D018926 - Anti-Allergic Agents D003879 - Dermatologic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

Artonol C

C30H28O7 (500.1835)

Artonol C is found in breadfruit. Artonol C is a constituent of the bark of Artocarpus communis (breadfruit) Constituent of the bark of Artocarpus communis (breadfruit). Artonol C is found in breadfruit and fruits.

Orcein

C28H24N2O7 (500.1583)

Once used as a food colouring but now banned throughout the EC Cudbear is a dye extracted from orchil lichens that produces colours in the purple range. It can be used to dye wool and silk, without the use of mordant. Cudbear was the first dye to be invented in modern times, and one of the few dyes to be credited to a named individual. Orcinol is extracted from archil lichen, Rocella tinctoria. It is then converted to orcein by ammonia and air. Orcein is a reddish-brown dye, orchil is a purple-blue dye. Orcein is also used as a stain in microscopy to visualize elastic fibers,Hepatitis B surface antigens and copper associated proteins. It is a mixture of phenoxazone derivates - hydroxyorceins, aminoorceins, and aminoorceinimines.

Lyoniresinol 9'-sulfate

C22H28O11S (500.1352)

Lyoniresinol 9-sulfate is found in green vegetables. Lyoniresinol 9-sulfate is a constituent of the roots of Polygonum cuspidatum (Japanese knotweed).

S)-2-(5(((1,2-Dihydro-3-methyl-1-oxobenzo(F)quinazolin-9-YL)methyl)amino)1-oxo-2-isoindolinyl)glutaric acid

C27H24N4O6 (500.1696)

Baohuoside II

C26H28O10 (500.1682)

(E)-N-(2-(((3-(4-Chlorophenyl)allyl)(methyl)amino)methyl)phenyl)-N-(2-hydroxyethyl)-4-methoxybenzenesulfonamide

C26H29ClN2O4S (500.1536)

Nocardicin A

C23H24N4O9 (500.1543)

Simotinib

C25H26ClFN4O4 (500.1627)

Ikarisoside A

C26H28O10 (500.1682)

Baohuoside II is a natural product found in Epimedium grandiflorum, Epimedium diphyllum, and other organisms with data available. IKarisoside A (Icarisoside-A) is a natural flavonol glycoside and has anti-inflammatory properties. IKarisoside A (Icarisoside-A) is a natural flavonol glycoside and has anti-inflammatory properties.

Curtisian P

C29H24O8 (500.1471)

sideroxylonal A

C26H28O10 (500.1682)

Gnetuhainin J

C29H24O8 (500.1471)

Genisteone

C26H28O10 (500.1682)

Quadrangularin C

C30H28O7 (500.1835)

Erythrolide P

C24H33ClO9 (500.1813)

Puerarin 4,6-diacetate

C25H24O11 (500.1319)

Guibourtinidol-(4alpha-

C29H24O8 (500.1471)

Gliocladinin B

C26H28O10 (500.1682)

Malibatol B

C28H20O9 (500.1107)

Gericudranin D

C29H24O8 (500.1471)

Benastatin A

C30H28O7 (500.1835)

Euchretin D

C30H28O7 (500.1835)

Apigenin 7-(6-crotonylglucoside)

C25H24O11 (500.1319)

2,3-di-O-Acetylfrangulin A

C25H24O11 (500.1319)

N-Demethyl-7-O-demethylcelesticetin

C22H32N2O9S (500.1828)

Euchretin E

C30H28O7 (500.1835)

Jasmolactone C

C26H28O10 (500.1682)

Singapurensine D

C25H28N2O9 (500.1795)

Epigallocatechin 5,3,5-trimethyl ether 3-O-gallate

C25H24O11 (500.1319)

Artonol C

C30H28O7 (500.1835)

MEGxp0_000848

C22H28O13 (500.153)

16198-01-9

C25H24O11 (500.1319)

1,4,5-trihydroxynaphthalene 1,4-di-O-beta-D-glucopyranoside|5-hydroxynaphthalene-1,4-di-O-beta-D-glucopyranoside|juglanoside F

C22H28O13 (500.153)

ST077077

C22H28O13 (500.153)

Penta-Ac-2,3,4,4,5-Pentahydroxyflavan

C25H24O11 (500.1319)

3-(2,4-di-O-acetyl-alpha-L-rhamnopyranosyl)emodin

C25H24O11 (500.1319)

Epimedoside B

C26H28O10 (500.1682)

(E)-2-(6-(bis(4-hydroxyphenyl)methylene)-5-(4-hydroxyphenyl)cyclohexa-2,4-dienylidene)-1-(4-hydroxyphenyl)ethanone|selaginellin G

C33H24O5 (500.1624)

3-(3,4-di-O-acetyl-alpha-L-rhamnopyranosyl)emodin

C25H24O11 (500.1319)

FT-0775735

C26H28O10 (500.1682)

22-O-methylagarotriose

C19H32O15 (500.1741)

C22H28O13

C22H28O13 (500.153)

solenolide B

C24H33ClO9 (500.1813)

Dendrofalconerol B

C30H28O7 (500.1835)

Diospyrosid

C22H28O13 (500.153)

(betaS,2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-3,5,7-trihydroxy-beta-(2,4,5-trihydroxyphenyl)-2H-1-benzopyran-6-propanoic acid methyl ester|6-[(1S)-3-methoxy-3-oxo-1-(2,4,5-trihydroxyphenyl)propyl]catechin

C25H24O11 (500.1319)

120722-04-5

C26H28O10 (500.1682)

5-Methylcoumarin-4-cellobioside

C22H28O13 (500.153)

mersinine A

C25H28N2O9 (500.1795)

Penta-Ac-Nubigenol

C25H24O11 (500.1319)

5-[(1E)-2-(4beta-D-glucopyranosyloxyphenyl)ethenyl]-4,7-dimethoxy-3-methyl-2H-1-benzopyran-2-one

C26H28O10 (500.1682)

gnetoflavanol E

C29H24O8 (500.1471)

5-Methylcoumarin-4-gentiobioside

C22H28O13 (500.153)

dendraol A

C30H28O7 (500.1835)

C26H28O10

C26H28O10 (500.1682)

Guibourtinidol-(4alpha->2)-3,5,3,4-tetrahydroxystilbene

C29H24O8 (500.1471)

gneafricanin A

C29H24O8 (500.1471)

grandinal

C26H28O10 (500.1682)

Curguligine B

C19H26Cl2O11 (500.0852)

(+)-gallocatechin-8-S-beta-D-glucopyranoside|excoecariphenol B

C21H24O12S (500.0988)

(6-trans-p-coumaroyl)-3-O-beta-D-glucopyranosyl-(5-acetyl)-2-deoxy-D-ribonic acid

C22H28O13 (500.153)

6-(beta-D-glucopyranosyl)oxy-7-hydroxy-3-[(2-oxo-2H-1-benzopyran-7-yl)oxy]-2H-1-benzopyran-2-one|daphneretusin A

C24H20O12 (500.0955)

gnaphaffine A

C25H24O11 (500.1319)

6,7-dihydroxy-3-methoxy-8-[2-oxo-2H-1-benzopyran-7-(O-beta-D-glucopyranosyl)-8-yl]-2H-1-benzopyran-2-one

C24H20O12 (500.0955)

3-O-p-coumaroyl-5-O-caffeoylquinic acid|3-p-(E)-coumaroyl-5-(E)-caffeoylquinic acid

C25H24O11 (500.1319)

1-O-trans-caffeoyl-5-O-trans-p-coumaroylquinic acid

C25H24O11 (500.1319)

Artorigidin C

C30H28O7 (500.1835)

Tri-Ac-Menegazziaic acid

C24H20O12 (500.0955)

Chloroenhydrin

C23H29ClO10 (500.1449)

2,4,6-trihydroxybenzoic acid-4-O-2,3,4,6-tetraacetylglucoside

C21H24O14 (500.1166)

mersirachine

C25H28N2O9 (500.1795)

Lawsoniaside

C22H28O13 (500.153)

gnetoflavanol B

C29H24O8 (500.1471)

1,4,5-trihydroxynaphthalene 1,5-di-O-beta-D-glucopyranoside|juglanoside G

C22H28O13 (500.153)

Penta-Ac-(-)-3,4,4,5,7-Pentahydroxyflavan

C25H24O11 (500.1319)

7-O-[beta-D-glucopyranosyl]-6-hydroxy-3-(2-oxo-2H-1-benzopyran-7-yl)-2H-1-benzopyran-2-one

C24H20O12 (500.0955)

16-Chloromilolide B

C24H33ClO9 (500.1813)

gneafricanin B

C29H24O8 (500.1471)

(2R,3R)-7,4-dihydroxy-5,3,5-trimethoxyflavan-3-O-gallate

C25H24O11 (500.1319)

5-Carboxypyranopelargonidin 3-O-beta-glucopyranoside

C24H20O12 (500.0955)

Drynachromoside A

C22H28O13 (500.153)

Haploperoside C

C22H28O13 (500.153)

relative retention time with respect to 9-anthracene Carboxylic Acid is 0.543 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.542

Fluticasone propionate

C25H31F3O5S (500.1844)

D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D000893 - Anti-Inflammatory Agents D018926 - Anti-Allergic Agents D003879 - Dermatologic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

6-methoxy-7-[3,4,5-trihydroxy-6-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxymethyl]oxan-2-yl]oxychromen-2-one

C22H28O13 (500.153)

6-hydroxy-8-(7-hydroxy-2-oxochromen-8-yl)-7-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one

C24H20O12 (500.0955)

C22H28O13_3-[6-({6-O-[(2R,3R,4R)-3,4-Dihydroxy-4-(hydroxymethyl)tetrahydro-2-furanyl]-beta-D-glucopyranosyl}oxy)-1-benzofuran-5-yl]propanoic acid

C22H28O13 (500.153)

6-methoxy-7-[3,4,5-trihydroxy-6-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxymethyl]oxan-2-yl]oxychromen-2-one

C22H28O13 (500.153)

Fluticasone

C25H31F3O5S (500.1844)

D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents CONFIDENCE standard compound; INTERNAL_ID 2831 D000893 - Anti-Inflammatory Agents D018926 - Anti-Allergic Agents D003879 - Dermatologic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

Catechin pentaacetate

C25H24O11 (500.1319)

Epicatechin Pentaacetate

C25H24O11 (500.1319)

6-hydroxy-8-(7-hydroxy-2-oxochromen-8-yl)-7-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one [IIN-based on: CCMSLIB00000846875]

C24H20O12 (500.0955)

6-hydroxy-8-(7-hydroxy-2-oxochromen-8-yl)-7-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one [IIN-based: Match]

C24H20O12 (500.0955)

Catechin Pentaacetate_major

C25H24O11 (500.1319)

Catechin Pentaacetate_0.7\\%

C25H24O11 (500.1319)

Cys Cys Glu Phe

C20H28N4O7S2 (500.1399)

Cys Cys Phe Glu

C20H28N4O7S2 (500.1399)

Cys Cys Ile Tyr

C21H32N4O6S2 (500.1763)

Cys Cys Leu Tyr

C21H32N4O6S2 (500.1763)

Cys Cys Tyr Ile

C21H32N4O6S2 (500.1763)

Cys Cys Tyr Leu

C21H32N4O6S2 (500.1763)

Cys Asp Thr Tyr

C20H28N4O9S (500.1577)

Cys Asp Tyr Thr

C20H28N4O9S (500.1577)

Cys Glu Cys Phe

C20H28N4O7S2 (500.1399)

Cys Glu Phe Cys

C20H28N4O7S2 (500.1399)

Cys Glu Ser Tyr

C20H28N4O9S (500.1577)

Cys Glu Tyr Ser

C20H28N4O9S (500.1577)

Cys Phe Cys Glu

C20H28N4O7S2 (500.1399)

Cys Phe Glu Cys

C20H28N4O7S2 (500.1399)

Cys Phe Met Thr

C21H32N4O6S2 (500.1763)

Cys Phe Thr Met

C21H32N4O6S2 (500.1763)

Cys His Asn Gln

C18H28N8O7S (500.1802)

Cys His Gln Asn

C18H28N8O7S (500.1802)

Cys Ile Cys Tyr

C21H32N4O6S2 (500.1763)

Cys Ile Tyr Cys

C21H32N4O6S2 (500.1763)

Cys Leu Cys Tyr

C21H32N4O6S2 (500.1763)

Cys Leu Tyr Cys

C21H32N4O6S2 (500.1763)

Cys Met Phe Thr

C21H32N4O6S2 (500.1763)

Cys Met Thr Phe

C21H32N4O6S2 (500.1763)

Cys Asn His Gln

C18H28N8O7S (500.1802)

Cys Asn Gln His

C18H28N8O7S (500.1802)

Cys Gln His Asn

C18H28N8O7S (500.1802)

Cys Gln Asn His

C18H28N8O7S (500.1802)

Cys Ser Glu Tyr

C20H28N4O9S (500.1577)

Cys Ser Tyr Glu

C20H28N4O9S (500.1577)

Cys Thr Asp Tyr

C20H28N4O9S (500.1577)

Cys Thr Phe Met

C21H32N4O6S2 (500.1763)

Cys Thr Met Phe

C21H32N4O6S2 (500.1763)

Cys Thr Tyr Asp

C20H28N4O9S (500.1577)

Cys Tyr Cys Ile

C21H32N4O6S2 (500.1763)

Cys Tyr Cys Leu

C21H32N4O6S2 (500.1763)

Cys Tyr Asp Thr

C20H28N4O9S (500.1577)

Cys Tyr Glu Ser

C20H28N4O9S (500.1577)

Cys Tyr Ile Cys

C21H32N4O6S2 (500.1763)

Cys Tyr Leu Cys

C21H32N4O6S2 (500.1763)

Cys Tyr Ser Glu

C20H28N4O9S (500.1577)

Cys Tyr Thr Asp

C20H28N4O9S (500.1577)

Asp Cys Thr Tyr

C20H28N4O9S (500.1577)

Asp Cys Tyr Thr

C20H28N4O9S (500.1577)

Asp Asp Asp His

C18H24N6O11 (500.1503)

Asp Asp His Asp

C18H24N6O11 (500.1503)

Asp His Asp Asp

C18H24N6O11 (500.1503)

Asp Thr Cys Tyr

C20H28N4O9S (500.1577)

Asp Thr Tyr Cys

C20H28N4O9S (500.1577)

Asp Tyr Cys Thr

C20H28N4O9S (500.1577)

Asp Tyr Thr Cys

C20H28N4O9S (500.1577)

Glu Cys Cys Phe

C20H28N4O7S2 (500.1399)

Glu Cys Phe Cys

C20H28N4O7S2 (500.1399)

Glu Cys Ser Tyr

C20H28N4O9S (500.1577)

Glu Cys Tyr Ser

C20H28N4O9S (500.1577)

Glu Phe Cys Cys

C20H28N4O7S2 (500.1399)

Glu Ser Cys Tyr

C20H28N4O9S (500.1577)

Glu Ser Tyr Cys

C20H28N4O9S (500.1577)

Glu Tyr Cys Ser

C20H28N4O9S (500.1577)

Glu Tyr Ser Cys

C20H28N4O9S (500.1577)

Phe Cys Cys Glu

C20H28N4O7S2 (500.1399)

Phe Cys Glu Cys

C20H28N4O7S2 (500.1399)

Phe Cys Met Thr

C21H32N4O6S2 (500.1763)

Phe Cys Thr Met

C21H32N4O6S2 (500.1763)

Phe Glu Cys Cys

C20H28N4O7S2 (500.1399)

Phe Met Cys Thr

C21H32N4O6S2 (500.1763)

Phe Met Thr Cys

C21H32N4O6S2 (500.1763)

Phe Thr Cys Met

C21H32N4O6S2 (500.1763)

Phe Thr Met Cys

C21H32N4O6S2 (500.1763)

Gly Met Met Tyr

C21H32N4O6S2 (500.1763)

Gly Met Tyr Met

C21H32N4O6S2 (500.1763)

Gly Tyr Met Met

C21H32N4O6S2 (500.1763)

His Cys Asn Gln

C18H28N8O7S (500.1802)

His Cys Gln Asn

C18H28N8O7S (500.1802)

His Asp Asp Asp

C18H24N6O11 (500.1503)

His Asn Cys Gln

C18H28N8O7S (500.1802)

His Asn Gln Cys

C18H28N8O7S (500.1802)

His Gln Cys Asn

C18H28N8O7S (500.1802)

His Gln Asn Cys

C18H28N8O7S (500.1802)

Ile Cys Cys Tyr

C21H32N4O6S2 (500.1763)

Ile Cys Tyr Cys

C21H32N4O6S2 (500.1763)

Ile Tyr Cys Cys

C21H32N4O6S2 (500.1763)

Leu Cys Cys Tyr

C21H32N4O6S2 (500.1763)

Leu Cys Tyr Cys

C21H32N4O6S2 (500.1763)

Leu Tyr Cys Cys

C21H32N4O6S2 (500.1763)

Met Cys Phe Thr

C21H32N4O6S2 (500.1763)

Met Cys Thr Phe

C21H32N4O6S2 (500.1763)

γ-Hydroxyphenylbutazone glucuronide

C25H28N2O9 (500.1795)

p-Hydroxyphenylbutazone glucuronide

C25H28N2O9 (500.1795)

Met Phe Cys Thr

C21H32N4O6S2 (500.1763)

Met Phe Thr Cys

C21H32N4O6S2 (500.1763)

Met Gly Met Tyr

C21H32N4O6S2 (500.1763)

Met Gly Tyr Met

C21H32N4O6S2 (500.1763)

Met Met Gly Tyr

C21H32N4O6S2 (500.1763)

Met Met Tyr Gly

C21H32N4O6S2 (500.1763)

Met Thr Cys Phe

C21H32N4O6S2 (500.1763)

Met Thr Phe Cys

C21H32N4O6S2 (500.1763)

Met Tyr Gly Met

C21H32N4O6S2 (500.1763)

Met Tyr Met Gly

C21H32N4O6S2 (500.1763)

Asn Cys His Gln

C18H28N8O7S (500.1802)

Asn Cys Gln His

C18H28N8O7S (500.1802)

Asn His Cys Gln

C18H28N8O7S (500.1802)

Asn His Gln Cys

C18H28N8O7S (500.1802)

Asn Gln Cys His

C18H28N8O7S (500.1802)

Asn Gln His Cys

C18H28N8O7S (500.1802)

Gln Cys His Asn

C18H28N8O7S (500.1802)

Gln Cys Asn His

C18H28N8O7S (500.1802)

Gln His Cys Asn

C18H28N8O7S (500.1802)

Gln His Asn Cys

C18H28N8O7S (500.1802)

Gln Asn Cys His

C18H28N8O7S (500.1802)

Gln Asn His Cys

C18H28N8O7S (500.1802)

Ser Cys Glu Tyr

C20H28N4O9S (500.1577)

Ser Cys Tyr Glu

C20H28N4O9S (500.1577)

Ser Glu Cys Tyr

C20H28N4O9S (500.1577)

Ser Glu Tyr Cys

C20H28N4O9S (500.1577)

Ser Tyr Cys Glu

C20H28N4O9S (500.1577)

Ser Tyr Glu Cys

C20H28N4O9S (500.1577)

Thr Cys Asp Tyr

C20H28N4O9S (500.1577)

Thr Cys Phe Met

C21H32N4O6S2 (500.1763)

Thr Cys Met Phe

C21H32N4O6S2 (500.1763)

Thr Cys Tyr Asp

C20H28N4O9S (500.1577)

Thr Asp Cys Tyr

C20H28N4O9S (500.1577)

Thr Asp Tyr Cys

C20H28N4O9S (500.1577)

Thr Phe Cys Met

C21H32N4O6S2 (500.1763)

Thr Phe Met Cys

C21H32N4O6S2 (500.1763)

Thr Met Cys Phe

C21H32N4O6S2 (500.1763)

Thr Met Phe Cys

C21H32N4O6S2 (500.1763)

Thr Tyr Cys Asp

C20H28N4O9S (500.1577)

Thr Tyr Asp Cys

C20H28N4O9S (500.1577)

Tyr Cys Cys Ile

C21H32N4O6S2 (500.1763)

Tyr Cys Cys Leu

C21H32N4O6S2 (500.1763)

Tyr Cys Asp Thr

C20H28N4O9S (500.1577)

Tyr Cys Glu Ser

C20H28N4O9S (500.1577)

Tyr Cys Ile Cys

C21H32N4O6S2 (500.1763)

Tyr Cys Leu Cys

C21H32N4O6S2 (500.1763)

Tyr Cys Ser Glu

C20H28N4O9S (500.1577)

Tyr Cys Thr Asp

C20H28N4O9S (500.1577)

Tyr Asp Cys Thr

C20H28N4O9S (500.1577)

Tyr Asp Thr Cys

C20H28N4O9S (500.1577)

Tyr Glu Cys Ser

C20H28N4O9S (500.1577)

Tyr Glu Ser Cys

C20H28N4O9S (500.1577)

Tyr Gly Met Met

C21H32N4O6S2 (500.1763)

Tyr Ile Cys Cys

C21H32N4O6S2 (500.1763)

Tyr Leu Cys Cys

C21H32N4O6S2 (500.1763)

Tyr Met Gly Met

C21H32N4O6S2 (500.1763)

Tyr Met Met Gly

C21H32N4O6S2 (500.1763)

Tyr Ser Cys Glu

C20H28N4O9S (500.1577)

Tyr Ser Glu Cys

C20H28N4O9S (500.1577)

Tyr Thr Cys Asp

C20H28N4O9S (500.1577)

Tyr Thr Asp Cys

C20H28N4O9S (500.1577)

Flutide

C25H31F3O5S (500.1844)

EUK 118

C22H25MnN2O8 (500.0991)

KN-93

C26H29ClN2O4S (500.1536)

D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors

Nap-TyrMe-OH

C28H24N2O7 (500.1583)

Tyr-Nap-OH

C28H24N2O7 (500.1583)

Orcein

C28H24N2O7 (500.1583)

D004396 - Coloring Agents

Lyoniresinol 9'-sulfate

C22H28O11S (500.1352)

4-methylumbelliferyl-beta-d-lactoside

C22H28O13 (500.153)

TMRM Perchlorate

C25H25ClN2O7 (500.135)

1,4-PHENYLENEBIS[[4-(4-AMINOPHENOXY)PHENYL]METHANONE]

C32H24N2O4 (500.1736)

Sibenadet hydrochloride

C22H29ClN2O5S2 (500.1206)

ICI 204,448 hydrochloride

C23H27Cl3N2O4 (500.1036)

ICI-204448 is a κ-opioid agonist with limited access to the CNS, ICI-204448 can displace the binding of the kappa-opioid ligand 3H-bremazocine from guinea pig cerebellum membranes[1].

[4,5,8-triacetyloxy-6-(1-acetyloxy-4-methylpent-3-enyl)naphthalen-1-yl] acetate

C26H28O10 (500.1682)

1,3-bis[4-(3-Aminophenoxy)benzoyl]benzene

C32H24N2O4 (500.1736)

Pitavastatin calcium

C25H23FNO4.1/2 Ca (500.0863)

Pitavastatin Calcium (NK-104 hemicalcium) is a potent hydroxymethylglutaryl-CoA (HMG-CoA) reductase inhibitor. Pitavastatin Calcium (NK-104 hemicalcium) inhibits cholesterol synthesis from acetic acid with an IC50 of 5.8 nM in HepG2 cells. Pitavastatin Calcium is an efficient hepatocyte low-density lipoprotein-cholesterol (LDL-C) receptor inducer. Pitavastatin Calcium also possesses anti-atherosclerotic, anti-asthmatic, anti-osteoarthritis, antineoplastic, neuroprotective, hepatoprotective and reno-protective effects[1][2][3][8].

4-hexyl-2-(4-hexyl-5-thiophen-2-yl-1,3-thiazol-2-yl)-5-thiophen-2-yl-1,3-thiazole

C26H32N2S4 (500.1448)

Regorafenib Monohydrate

C21H17ClF4N4O4 (500.0874)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor Regorafenib (BAY 73-4506) monohydrate is an orally active and potent multi-targeted receptor tyrosine kinase inhibitor, with IC50 values of 13/4.2/46, 22, 7, 1.5 and 2.5 nM for VEGFR1/2/3, PDGFRβ, Kit, RET and Raf-1, respectively. Regorafenib monohydrate shows very robust antitumor and antiangiogenic activity[1].

4-Methylumbelliferyl beta-D-cellobioside

C22H28O13 (500.153)

9,9-spirobi[fluoren]-2-yldiphenylphosphane

C37H25P (500.1694)

6-Hydroxy Warfarin β-D-Glucuronide

C25H24O11 (500.1319)

Uredofos

C19H25N4O6PS2 (500.0953)

C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent

5-(4-CHLOROPHENYL)-1-(2,4-DICHLOROPHENYL)-4-METHYLPYRAZOLE-3-CARBOXYLICACID

C27H34BrO2P (500.148)

(6R,7R)-3-Hydroxy-8-oxo-7-[(phenylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid diphenyl methyl ester

C28H24N2O5S (500.1406)

Benzoic acid, 4-(((2,3-dihydro-6-((2-methylpropyl)(2-thiazolylsulfonyl)amino)-1H-inden-5-yl)oxy)methyl)-3-methyl-

C25H28N2O5S2 (500.144)

Simotinib

C25H26ClFN4O4 (500.1627)

Eotube

C20H28N4O9S (500.1577)

Haploperoside

C22H28O13 (500.153)

A natural product found in Citropsis articulata.

Quaterrylene

C40H20 (500.1565)

5-hydroxy-2-methylchromone-7-O-rutinoside

C22H28O13 (500.153)

A disaccharide derivative that consists of 5-hydroxy-2-methylchromone substituted by a rutinosyl group at position 7 via a glycosidic linkage. Isolated from Crossosoma bigelovii, it exhibits antineoplastic activity.

1843U89;(2S)-2-(5-{[(3-Methyl-1-oxo-1,2-dihydrobenzo[f]quinazolin-9-yl)me thyl]amino}-1-oxo-1,3-dihydro-2H-isoindol-2-yl)pentanedioic acid

C27H24N4O6 (500.1696)

S)-2-(5(((1,2-Dihydro-3-methyl-1-oxobenzo(F)quinazolin-9-YL)methyl)amino)1-oxo-2-isoindolinyl)glutaric acid

C27H24N4O6 (500.1696)

C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite C471 - Enzyme Inhibitor > C2021 - Thymidylate Synthase Inhibitor D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists D000970 - Antineoplastic Agents

(+)-Neocarzinostatin chromophore aglycone

C28H20O9 (500.1107)

2-glutathion-S-yl-3-(4-nitrophenyl) propionic acid

C19H24N4O10S (500.1213)

(2S)-2-amino-4-[4-[(E)-C-[[(3S)-1-[(R)-carboxy-(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]carbamoyl]-N-hydroxycarbonimidoyl]phenoxy]butanoic acid

C23H24N4O9 (500.1543)

GS-Hpv II

C20H26N3O10S- (500.1339)

GS-Hpv I

C20H26N3O10S- (500.1339)

(3S,alphaR)-3-[[[4-[(R)-3-Amino-3-carboxypropoxy]phenyl]-[(Z)-hydroxyimino]acetyl]amino]-alpha-(4-hydroxyphenyl)-2-oxo-1-azetidineacetic acid

C23H24N4O9 (500.1543)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

7-(4-hydroxyphenyl)-11-oxo-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,8-dioxatricyclo[7.3.1.05,13]trideca-1(12),3,5(13),6,9-pentaene-3-carboxylic acid

C24H20O12 (500.0955)

[4-[(2-Chlorophenyl)methylsulfonyl]-3-nitrophenyl]-[4-(2-pyridinyl)-1-piperazinyl]methanone

C23H21ClN4O5S (500.0921)

2-[cyclopentyl-[1-oxo-2-(5-thiophen-2-yl-2-tetrazolyl)ethyl]amino]-N-(2-oxolanylmethyl)-2-thiophen-2-ylacetamide

C23H28N6O3S2 (500.1664)

2-[4-(4-methoxyphenyl)-4-methyl-2,5-dioxo-1-imidazolidinyl]-N-[4-(6-methyl-1,3-benzothiazol-2-yl)phenyl]acetamide

C27H24N4O4S (500.1518)

2-(4-morpholinyl)-9-(3-thiophenyl)-N-[[6-(trifluoromethyl)-1H-benzimidazol-2-yl]methyl]-6-purinamine

C22H19F3N8OS (500.1355)

6,9-difluoro-11-hydroxy-17-(3-hydroxy-2-oxopropyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioic acid S-(fluoromethyl) ester

C25H31F3O5S (500.1844)

2-[(1R,3R,4aS,9aR)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(2,2,2-trifluoroethyl)acetamide

C22H23F3N2O6S (500.1229)

N-[(2R,3R)-4-[(4-chlorophenyl)sulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-2-fluoro-N-methylbenzamide

C23H30ClFN2O5S (500.1548)

2-[(1S,3S,4aS,9aR)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2,2,2-trifluoroethyl)acetamide

C22H23F3N2O6S (500.1229)

2-[(1S,3S,4aR,9aS)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(2,2,2-trifluoroethyl)acetamide

C22H23F3N2O6S (500.1229)

N-[(2R,3S)-4-[(4-chlorophenyl)sulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-2-fluoro-N-methylbenzamide

C23H30ClFN2O5S (500.1548)

N-[[(4R,5R)-8-(4-fluorophenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide

C22H29FN2O6S2 (500.1451)

N-[[(4R,5R)-8-(4-fluorophenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide

C22H29FN2O6S2 (500.1451)

N-[[(4S,5R)-8-(4-fluorophenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide

C22H29FN2O6S2 (500.1451)

N-[[(4R,5S)-8-(4-fluorophenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide

C22H29FN2O6S2 (500.1451)

2-[(1R,3R,4aR,9aS)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2,2,2-trifluoroethyl)acetamide

C22H23F3N2O6S (500.1229)

N-[(2S,3R)-4-[(4-chlorophenyl)sulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-2-fluoro-N-methylbenzamide

C23H30ClFN2O5S (500.1548)

N-[(2R,3S)-4-[(4-chlorophenyl)sulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-2-fluoro-N-methylbenzamide

C23H30ClFN2O5S (500.1548)

N-[[(4S,5S)-8-(4-fluorophenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide

C22H29FN2O6S2 (500.1451)

N-[[(4S,5S)-8-(4-fluorophenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide

C22H29FN2O6S2 (500.1451)

N-[[(4S,5R)-8-(4-fluorophenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide

C22H29FN2O6S2 (500.1451)

N-[[(4R,5S)-8-(4-fluorophenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide

C22H29FN2O6S2 (500.1451)

2-[(1S,3R,4aS,9aR)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2,2,2-trifluoroethyl)acetamide

C22H23F3N2O6S (500.1229)

N-[(2S,3S)-4-[(4-chlorophenyl)sulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-2-fluoro-N-methylbenzamide

C23H30ClFN2O5S (500.1548)

N-[(2S,3R)-4-[(4-chlorophenyl)sulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-2-fluoro-N-methylbenzamide

C23H30ClFN2O5S (500.1548)

N-[(2S,3S)-4-[(4-chlorophenyl)sulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-2-fluoro-N-methylbenzamide

C23H30ClFN2O5S (500.1548)

(beta-D-glucopyranosyloxymethyl)deoxyuridine 5-monophosphate

C16H25N2O14P (500.1043)

A pyrimidine 2-deoxyribonucleoside 5-monophosphate having beta-D-glucopyranosyloxymethyluracil (base J) as the nucleobase

Glu-Phe-Cys-Cys

C20H28N4O7S2 (500.1399)

1,2-diacetyl-3-[beta-D-glucosyl-(1->6)-beta-D-galactosyl]-sn-glycerol

C19H32O15 (500.1741)

(2S)-2-ammonio-4-{4-[(1Z)-2-({(3S)-1-[(R)-carboxy(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl}amino)-N-hydroxy-2-oxoethanimidoyl]phenoxy}butanoate

C23H24N4O9 (500.1543)

(2S,3S,4S,5R)-6-[7-carbamoyl-5-hydroxy-1-(4-phenylbutan-2-yl)indol-6-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

C25H28N2O9 (500.1795)

6-({5-[3-(2H-1,3-benzodioxol-5-yl)-3-oxopropanoyl]-1-benzofuran-4-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C24H20O12 (500.0955)

(2S,3S,4S,5R)-6-[7-carbamoyl-6-hydroxy-1-(4-phenylbutan-2-yl)indol-5-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

C25H28N2O9 (500.1795)

7-(4-hydroxyphenyl)-11-oxo-6-[(2S,4S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,8-dioxatricyclo[7.3.1.05,13]trideca-1(12),3,5(13),6,9-pentaene-3-carboxylic acid

C24H20O12 (500.0955)

Fluticasone propionate (Flonase, Veramyst)

C25H31F3O5S (500.1844)

6-Hydroxy-8-(7-hydroxy-2-oxochromen-8-yl)-7-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one

C24H20O12 (500.0955)

[2-Acetyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropyl] acetate

C19H32O15 (500.1741)

Isonocardicin A

C23H24N4O9 (500.1543)

A nocardicin in which the beta-lactam moiety is substituted at position 1 by a carboxy(4-hydroxyphenyl)methyl group and at position 3 by a [(2Z)-2-(hydroxyimino)-2-(4-hydroxyphenyl)acetyl]nitrilo group in which the phenolic hydroxy group is substituted by a (3S)-3-amino-3-carboxypropyl group.

Lyoniresinol 9-sulfate

C22H28O11S (500.1352)

isonocardicin A zwitterion

C23H24N4O9 (500.1543)

An L-alpha-amino acid zwitterion resulting from the transfer of a proton from the carboxy group to the amino group of isonocardicin A.

ST 22:5;O8;S

C22H28O11S (500.1352)

ST 23:4;O7;S

C23H32O10S (500.1716)

4-[(2s,3s)-3-(3,5-dihydroxyphenyl)-4-hydroxy-6-[(1e)-2-(4-hydroxy-3-methoxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-2-yl]benzene-1,2-diol

C29H24O8 (500.1471)

(12r)-3,10,17-trihydroxy-7,7,21,21-tetramethyl-12-(prop-1-en-2-yl)-8,20,26-trioxahexacyclo[12.12.0.0²,¹¹.0⁴,⁹.0¹⁶,²⁵.0¹⁹,²⁴]hexacosa-1(14),2,4(9),5,10,16,18,22,24-nonaen-15-one

C30H28O7 (500.1835)

2-(3,5-diformyl-2,4,6-trihydroxyphenyl)-5,7-dihydroxy-3-isopropyl-4-(2-methylpropyl)-3,4-dihydro-2h-1-benzopyran-6,8-dicarbaldehyde

C26H28O10 (500.1682)

methyl (3r)-4-{6-[(2r,4r,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]-1,5-dihydroxy-9,10-dioxoanthracen-2-yl}-3-hydroxy-3-methylbutanoate

C26H28O10 (500.1682)

(11s,12r)-6-(3,5-dihydroxyphenyl)-5,12-bis(4-hydroxyphenyl)-4,13-dioxatricyclo[7.4.0.0³,⁷]trideca-1(9),2,7-triene-8,11-diol

C29H24O8 (500.1471)

(8r,10s)-10-{[(2r,3r,4r,5r,6s)-4,5-dihydroxy-3-methoxy-6-methyloxan-2-yl]oxy}-1,8,11-trihydroxy-8-methyl-9,10-dihydro-7h-tetracene-5,12-dione

C26H28O10 (500.1682)

4,7-dimethoxy-3-methyl-5-[(1e)-2-(4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)ethenyl]chromen-2-one

C26H28O10 (500.1682)

5-[(2s,3s)-7-[(1e)-2-(3,5-dihydroxyphenyl)ethenyl]-6-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-2,3-dihydro-1-benzofuran-3-yl]benzene-1,3-diol

C29H24O8 (500.1471)

(1e,2r,3r)-3-(2,4-dihydroxyphenyl)-2-(3,5-dihydroxyphenyl)-1-[(4-hydroxy-3-methoxyphenyl)methylidene]-2,3-dihydroindene-4,6-diol

C29H24O8 (500.1471)

(9r)-8-[2-(4-hydroxyphenyl)ethyl]-4-methoxy-9-[(4-methoxyphenyl)methyl]-9h-xanthene-2,3,6-triol

C30H28O7 (500.1835)

(2r,3s)-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

C21H24O12S (500.0988)

(2s,3r,4s,5s,6r)-2-[(3-hydroxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}naphthalen-1-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C22H28O13 (500.153)

5-[(2r,3s)-8-formyl-5,7-dihydroxy-3-isopropyl-6-(3-methylbutanoyl)-3,4-dihydro-2h-1-benzopyran-2-yl]-2,4,6-trihydroxybenzene-1,3-dicarbaldehyde

C26H28O10 (500.1682)

4-[(2s,3s)-3-(3,5-dihydroxyphenyl)-4-hydroxy-6-[(1e)-2-(4-hydroxy-3-methoxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-2-yl]benzene-1,3-diol

C29H24O8 (500.1471)

7-{[6-({[3,4-dihydroxy-4-(hydroxymethyl)-3-methyloxolan-2-yl]oxy}methyl)-3,4,5-trihydroxy-3-methyloxan-2-yl]oxy}-6-hydroxychromen-2-one

C22H28O13 (500.153)

11,12,16-trimethyl (1r,12r,13r,16r,23r)-12-hydroxy-6,8-dioxa-11,20-diazahexacyclo[14.6.1.0¹,¹³.0²,¹⁰.0⁵,⁹.0²⁰,²³]tricosa-2(10),3,5(9),17-tetraene-11,12,16-tricarboxylate

C25H28N2O9 (500.1795)

(8s,9s)-16-(3,4-dihydroxyphenyl)-8-(4-hydroxyphenyl)-15-oxatetracyclo[8.6.1.0²,⁷.0¹⁴,¹⁷]heptadeca-1(16),2,4,6,10(17),11,13-heptaene-3,4,6,9,12-pentol

C28H20O9 (500.1107)

7-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-6-methoxychromen-2-one

C22H28O13 (500.153)

16,18-dimethyl 18-hydroxy-23-methoxy-11,13,20-trioxa-3,16-diazaoctacyclo[15.6.2.0¹,¹⁹.0²,⁶.0³,²¹.0⁶,¹⁷.0⁷,¹⁵.0¹⁰,¹⁴]pentacosa-7(15),8,10(14)-triene-16,18-dicarboxylate

C25H28N2O9 (500.1795)

12-(acetyloxy)-6-chloro-14,15-dihydroxy-2,11,15-trimethyl-7-methylidene-3-oxo-4,18-dioxatetracyclo[8.7.1.0¹,⁵.0¹¹,¹⁶]octadecan-17-yl acetate

C24H33ClO9 (500.1813)

3-(2,4-dihydroxyphenyl)-2-(3,5-dihydroxyphenyl)-1-[(4-hydroxy-3-methoxyphenyl)methylidene]-2,3-dihydroindene-4,6-diol

C29H24O8 (500.1471)

5,7-dihydroxy-2-(4-hydroxyphenyl)-8-(3-methylbut-2-en-1-yl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}chromen-4-one

C26H28O10 (500.1682)

6,7-dihydroxy-7-(hydroxymethyl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-5-yl 4-hydroxybenzoate

C22H28O13 (500.153)

5-(acetyloxy)-2-[(4,5-dihydroxy-7-methyl-9,10-dioxoanthracen-2-yl)oxy]-4-hydroxy-6-methyloxan-3-yl acetate

C25H24O11 (500.1319)

(4s,5s,11s,12r)-5-(3,5-dihydroxyphenyl)-4,11-bis(4-hydroxyphenyl)-3,10-dioxatricyclo[7.4.0.0²,⁶]trideca-1,6,8-triene-7,12-diol

C29H24O8 (500.1471)

12alpha-Hydroxyevodol

C26H28O10 (500.1682)

{"Ingredient_id": "HBIN000707","Ingredient_name": "12alpha-Hydroxyevodol","Alias": "12alpha-hydroxyevodol; 12\u03b1-hydroxyevodol","Ingredient_formula": "C26H28O10","Ingredient_Smile": "CC1(C2=C(C(=O)C3(C(C24COC(=O)CC4O1)CC(C5(C36C(O6)C(=O)OC5C7=COC=C7)C)O)C)O)C","Ingredient_weight": "500.5 g/mol","OB_score": "19.40751811","CAS_id": "NA","SymMap_id": "SMIT01183;SMIT15841","TCMID_id": "31192;10117","TCMSP_id": "MOL003976","TCM_ID_id": "19312","PubChem_id": "129317030","DrugBank_id": "NA"}

5-methylcoumarin-4-cellobioside

C22H28O13 (500.153)

{"Ingredient_id": "HBIN011802","Ingredient_name": "5-methylcoumarin-4-cellobioside","Alias": "NA","Ingredient_formula": "C22H28O13","Ingredient_Smile": "CC1=C2C(=CC=C1)OC(=O)C=C2OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)CO)O)O)O)O)O","Ingredient_weight": "500.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14248","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "196631","DrugBank_id": "NA"}

5-methylcoumarin-4-gentiobioside

C22H28O13 (500.153)

{"Ingredient_id": "HBIN011803","Ingredient_name": "5-methylcoumarin-4-gentiobioside","Alias": "NA","Ingredient_formula": "C22H28O13","Ingredient_Smile": "CC1=C2C(=CC=C1)OC(=O)C=C2OC3C(C(C(C(O3)COC4C(C(C(C(O4)CO)O)O)O)O)O)O","Ingredient_weight": "500.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14249","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "3080987","DrugBank_id": "NA"}

methyl (3s)-3-[(2r,3s)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2h-1-benzopyran-6-yl]-3-(2,4,5-trihydroxyphenyl)propanoate

C25H24O11 (500.1319)

12-(acetyloxy)-9-(chloromethyl)-2,3-dihydroxy-4,13,18-trimethyl-5-oxo-6,17-dioxatetracyclo[11.5.0.0³,⁷.0¹⁶,¹⁸]octadec-8-en-14-yl acetate

C24H33ClO9 (500.1813)

(1r,2s,3r)-2-(3,5-dihydroxyphenyl)-1-[(r)-ethoxy(4-hydroxyphenyl)methyl]-3-(4-hydroxyphenyl)-2,3-dihydro-1h-indene-4,6-diol

C30H28O7 (500.1835)

(1z,2s,3s)-3-(3,4-dihydroxyphenyl)-2-(3,5-dihydroxyphenyl)-1-[(4-hydroxy-3-methoxyphenyl)methylidene]-2,3-dihydroindene-4,6-diol

C29H24O8 (500.1471)

(2r,3r,4r)-4-{2-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]-4,6-dihydroxyphenyl}-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,7-diol

C29H24O8 (500.1471)

(2r)-2-amino-4-{4-[(e)-{[(3s)-1-[(r)-carboxy(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]-c-hydroxycarbonimidoyl}(hydroxyimino)methyl]phenoxy}butanoic acid

C23H24N4O9 (500.1543)

5-[8-formyl-5,7-dihydroxy-3-isopropyl-6-(3-methylbutanoyl)-3,4-dihydro-2h-1-benzopyran-2-yl]-2,4,6-trihydroxybenzene-1,3-dicarbaldehyde

C26H28O10 (500.1682)

(2s,3s,4s,5r,6s)-3-(acetyloxy)-6-[(4,5-dihydroxy-7-methyl-9,10-dioxoanthracen-2-yl)oxy]-5-hydroxy-2-methyloxan-4-yl acetate

C25H24O11 (500.1319)

(2r,3r,4s)-2-(3,5-diformyl-2,4,6-trihydroxyphenyl)-5,7-dihydroxy-3-isopropyl-4-(2-methylpropyl)-3,4-dihydro-2h-1-benzopyran-6,8-dicarbaldehyde

C26H28O10 (500.1682)

(2s,3r,4s,5s,6r)-2-[(4-hydroxy-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}naphthalen-1-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C22H28O13 (500.153)

5,7-dihydroxy-2-(4-hydroxyphenyl)-8-(3-methylbut-2-en-1-yl)-3-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}chromen-4-one

C26H28O10 (500.1682)

4-[3-(3,5-dihydroxyphenyl)-4-hydroxy-6-[2-(4-hydroxy-3-methoxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-2-yl]benzene-1,3-diol

C29H24O8 (500.1471)

2,6-dihydroxy-4-{[(2s,3r,4s,5r,6r)-3,4,5-tris(acetyloxy)-6-[(acetyloxy)methyl]oxan-2-yl]oxy}benzoic acid

C21H24O14 (500.1166)

(2s)-2-amino-4-{4-[(z)-{[(3s)-1-[(s)-carboxy(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]-c-hydroxycarbonimidoyl}(hydroxyimino)methyl]phenoxy}butanoic acid

C23H24N4O9 (500.1543)

(2s,3r,4r,5s,6s)-3-(acetyloxy)-2-[(4,5-dihydroxy-7-methyl-9,10-dioxoanthracen-2-yl)oxy]-5-hydroxy-6-methyloxan-4-yl acetate

C25H24O11 (500.1319)

(2s,3r,4s,5s,6r)-2-[(5-hydroxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}naphthalen-1-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C22H28O13 (500.153)

(2r,3s,4s)-2-(3,5-diformyl-2,4,6-trihydroxyphenyl)-5,7-dihydroxy-3-isopropyl-4-(2-methylpropyl)-3,4-dihydro-2h-1-benzopyran-6,8-dicarbaldehyde

C26H28O10 (500.1682)

7-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-6-methoxychromen-2-one

C22H28O13 (500.153)

(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-{[4'-methoxy-4-(4-methoxyphenyl)-[1,1'-biphenyl]-2,6-diyl]oxy}oxane-3,4,5-triol

C26H28O10 (500.1682)

2-(3,4-dihydroxyphenyl)ethyl 1-hydroxy-9-[2-(4-hydroxyphenyl)ethoxy]-6-oxo-1h,4ah,5h,8h,9h,9ah-pyrano[3,4-d]oxepine-4-carboxylate

C26H28O10 (500.1682)

6-(acetyloxy)-2,4',5-trihydroxy-4-(4-hydroxyphenyl)-[1,1'-biphenyl]-3-yl 3-phenylpropanoate

C29H24O8 (500.1471)

16-(3,4-dihydroxyphenyl)-8-(4-hydroxyphenyl)-15-oxatetracyclo[8.6.1.0²,⁷.0¹⁴,¹⁷]heptadeca-1(16),2,4,6,10(17),11,13-heptaene-3,4,6,9,12-pentol

C28H20O9 (500.1107)

4-{2-[2-(3,4-dihydroxyphenyl)ethenyl]-4,6-dihydroxyphenyl}-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,7-diol

C29H24O8 (500.1471)

2,4-dihydroxy-7-(4-hydroxy-2-methoxy-6-methylphenyl)-9-methoxy-12,12-dimethyltetracene-5,6,11-trione

C29H24O8 (500.1471)

methyl 3-[2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2h-1-benzopyran-6-yl]-3-(2,4,5-trihydroxyphenyl)propanoate

C25H24O11 (500.1319)

(1r,4s,5r,6s,7r,8s,9s)-4,5-dihydroxy-9-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,10-dioxatricyclo[5.3.1.0⁴,⁸]undecan-6-yl 4-hydroxybenzoate

C22H28O13 (500.153)

(7s,9r)-6,9-dihydroxy-2-methoxy-9-methyl-7-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-8,10-dihydro-7h-tetracene-5,12-dione

C26H28O10 (500.1682)

(2r,3s)-3,7-bis(acetyloxy)-2-[3,4-bis(acetyloxy)phenyl]-3,4-dihydro-2h-1-benzopyran-5-yl acetate

C25H24O11 (500.1319)

4,5-dihydroxy-9-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,10-dioxatricyclo[5.3.1.0⁴,⁸]undecan-6-yl 4-hydroxybenzoate

C22H28O13 (500.153)

methyl (3r)-3-[(2r,3s)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2h-1-benzopyran-6-yl]-3-(2,4,5-trihydroxyphenyl)propanoate

C25H24O11 (500.1319)

5,7-dihydroxy-2-(4-hydroxyphenyl)-8-(3-methylbut-2-en-1-yl)-3-{[(2s,3s,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}chromen-4-one

C26H28O10 (500.1682)

3-(acetyloxy)-6-[(4,5-dihydroxy-7-methyl-9,10-dioxoanthracen-2-yl)oxy]-5-hydroxy-2-methyloxan-4-yl acetate

C25H24O11 (500.1319)

4,7-dimethoxy-3-methyl-5-[2-(4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)ethenyl]chromen-2-one

C26H28O10 (500.1682)

6,9-dihydroxy-2-methoxy-9-methyl-7-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-8,10-dihydro-7h-tetracene-5,12-dione

C26H28O10 (500.1682)

(1e,2s,3s)-3-(2,4-dihydroxyphenyl)-2-(3,5-dihydroxyphenyl)-1-[(4-hydroxy-3-methoxyphenyl)methylidene]-2,3-dihydroindene-4,6-diol

C29H24O8 (500.1471)

4-[3-(3,5-dihydroxyphenyl)-4-hydroxy-6-[2-(4-hydroxy-3-methoxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-2-yl]benzene-1,2-diol

C29H24O8 (500.1471)

5-[11-(2,4-dihydroxyphenyl)-12-(3,5-dihydroxyphenyl)-8-hydroxy-5,10-dioxatricyclo[7.3.0.0²,⁶]dodeca-1,3,6,8-tetraen-4-yl]benzene-1,3-diol

C28H20O9 (500.1107)

(11r,12s)-5-(3,5-dihydroxyphenyl)-4,11-bis(4-hydroxyphenyl)-3,10-dioxatricyclo[7.4.0.0²,⁶]trideca-1,6,8-triene-7,12-diol

C29H24O8 (500.1471)

6-methoxy-7-[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]methyl}oxan-2-yl)oxy]chromen-2-one

C22H28O13 (500.153)

2-{[(1,3-dimethyl-2,4-dioxopteridin-6-yl)(hydroxy)methylidene]amino}-n-[2-(methoxycarbonyl)phenyl]-4-(methylsulfanyl)butanimidic acid

C22H24N6O6S (500.1478)

(4s,5s,11r,12s)-5-(3,5-dihydroxyphenyl)-4,11-bis(4-hydroxyphenyl)-3,10-dioxatricyclo[7.4.0.0²,⁶]trideca-1,6,8-triene-7,12-diol

C29H24O8 (500.1471)

[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-{[5-hydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxy}oxan-2-yl]methyl (2e)-but-2-enoate

C25H24O11 (500.1319)

3,11,12-trimethyl (6ar,12r,12ar)-12-hydroxy-10-methoxy-4-[(1e)-3-oxoprop-1-en-1-yl]-1h,2h,5h,6h,12ah-pyrrolo[2,3-n]phenanthridine-3,11,12-tricarboxylate

C25H28N2O9 (500.1795)

(1r,2r,5r,6s,10r,11r,12s,14r,15s,16s,17r)-12-(acetyloxy)-6-chloro-14,15-dihydroxy-2,11,15-trimethyl-7-methylidene-3-oxo-4,18-dioxatetracyclo[8.7.1.0¹,⁵.0¹¹,¹⁶]octadecan-17-yl acetate

C24H33ClO9 (500.1813)

6-methoxy-7-{[(2s,3r,4s,5s)-3,4,5-trihydroxy-6-({[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}chromen-2-one

C22H28O13 (500.153)

6-(3,5-dihydroxyphenyl)-5,12-bis(4-hydroxyphenyl)-4,13-dioxatricyclo[7.4.0.0³,⁷]trideca-1,3(7),8-triene-8,11-diol

C29H24O8 (500.1471)

(3,4,5-trihydroxy-6-{[5-hydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxy}oxan-2-yl)methyl but-2-enoate

C25H24O11 (500.1319)

2-{[4,5-dihydroxy-2-(hydroxymethyl)-6-{[4,5,6-trihydroxy-2-(hydroxymethyl)cyclohex-2-en-1-yl]oxy}oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C19H32O15 (500.1741)

(2r,3r)-7-hydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-5-methoxy-3,4-dihydro-2h-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate

C25H24O11 (500.1319)

11,17-dihydroxy-7,7,20,20-tetramethyl-4-(3-methylbut-2-en-1-yl)-2,6,19,25-tetraoxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²⁴.0¹⁸,²³]pentacosa-1(14),3,5(10),8,11,15(24),16,18(23),21-nonaen-13-one

C30H28O7 (500.1835)

(2s)-2-{[(1,3-dimethyl-2,4-dioxopteridin-6-yl)(hydroxy)methylidene]amino}-n-[2-(methoxycarbonyl)phenyl]-4-(methylsulfanyl)butanimidic acid

C22H24N6O6S (500.1478)

(2r)-n-[(1s,2s)-2-hydroxy-1-[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-{[2-(2-hydroxybenzoyloxy)ethyl]sulfanyl}oxan-2-yl]propyl]pyrrolidine-2-carboximidic acid

C22H32N2O9S (500.1828)

(2r,3r,4r)-2-(3,5-diformyl-2,4,6-trihydroxyphenyl)-5,7-dihydroxy-3-isopropyl-4-(2-methylpropyl)-3,4-dihydro-2h-1-benzopyran-6,8-dicarbaldehyde

C26H28O10 (500.1682)

(5r,6r,11s,12r)-6-(3,5-dihydroxyphenyl)-5,12-bis(4-hydroxyphenyl)-4,13-dioxatricyclo[7.4.0.0³,⁷]trideca-1,3(7),8-triene-8,11-diol

C29H24O8 (500.1471)

(1r,2r,5r,6s,10s,11s,12s,14r,15s,16s,17r)-12-(acetyloxy)-6-chloro-14,15-dihydroxy-2,11,15-trimethyl-7-methylidene-3-oxo-4,18-dioxatetracyclo[8.7.1.0¹,⁵.0¹¹,¹⁶]octadecan-17-yl acetate

C24H33ClO9 (500.1813)

(2r,3r)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-6,8-bis[(4-hydroxyphenyl)methyl]-2,3-dihydro-1-benzopyran-4-one

C29H24O8 (500.1471)

5,13,17,19-tetrahydroxy-22,22-dimethyl-15-oxo-7-pentylpentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁶,²¹]docosa-1,3(12),4(9),5,7,10,13,16,18,20-decaene-6-carboxylic acid

C30H28O7 (500.1835)

5-(3,5-dihydroxyphenyl)-4,11-bis(4-hydroxyphenyl)-3,10-dioxatricyclo[7.4.0.0²,⁶]trideca-1,6,8-triene-7,12-diol

C29H24O8 (500.1471)

(1r,3r,4s,5r)-3-{[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-1,5-dihydroxy-4-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}cyclohexane-1-carboxylic acid

C25H24O11 (500.1319)

3,5,7-trihydroxy-2-(4-hydroxyphenyl)-6,8-bis[(4-hydroxyphenyl)methyl]-2,3-dihydro-1-benzopyran-4-one

C29H24O8 (500.1471)

(8s,9r)-16-(3,4-dihydroxyphenyl)-8-(4-hydroxyphenyl)-15-oxatetracyclo[8.6.1.0²,⁷.0¹⁴,¹⁷]heptadeca-1(16),2,4,6,10(17),11,13-heptaene-3,4,6,9,12-pentol

C28H20O9 (500.1107)

(12s)-3,10,17-trihydroxy-7,7,21,21-tetramethyl-12-(prop-1-en-2-yl)-8,20,26-trioxahexacyclo[12.12.0.0²,¹¹.0⁴,⁹.0¹⁶,²⁵.0¹⁹,²⁴]hexacosa-1(14),2,4(9),5,10,16,18,22,24-nonaen-15-one

C30H28O7 (500.1835)

(1s,2r,3r,4r,7s,8e,12r,13s,14s,16s,18r)-12-(acetyloxy)-9-(chloromethyl)-2,3-dihydroxy-4,13,18-trimethyl-5-oxo-6,17-dioxatetracyclo[11.5.0.0³,⁷.0¹⁶,¹⁸]octadec-8-en-14-yl acetate

C24H33ClO9 (500.1813)

(1s,4ar,5s,6r,7s,7as)-6,7-dihydroxy-7-(hydroxymethyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-5-yl 4-hydroxybenzoate

C22H28O13 (500.153)

3,11,12-trimethyl 12-hydroxy-10-methoxy-4-(3-oxoprop-1-en-1-yl)-1h,2h,5h,6h,12ah-pyrrolo[2,3-n]phenanthridine-3,11,12-tricarboxylate

C25H28N2O9 (500.1795)

(2r)-2-amino-4-{4-[(z)-{[(3s)-1-[(r)-carboxy(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]-c-hydroxycarbonimidoyl}(hydroxyimino)methyl]phenoxy}butanoic acid

C23H24N4O9 (500.1543)

(1r,2s,3r)-2-(3,5-dihydroxyphenyl)-1-[(s)-ethoxy(4-hydroxyphenyl)methyl]-3-(4-hydroxyphenyl)-2,3-dihydro-1h-indene-4,6-diol

C30H28O7 (500.1835)

8-[2-(4-hydroxyphenyl)ethyl]-4-methoxy-9-[(4-methoxyphenyl)methyl]-9h-xanthene-2,3,6-triol

C30H28O7 (500.1835)

5-{7-[(1e)-2-(3,5-dihydroxyphenyl)ethenyl]-6-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-2,3-dihydro-1-benzofuran-3-yl}benzene-1,3-diol

C29H24O8 (500.1471)

2-amino-4-{4-[(z)-({1-[carboxy(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl}-c-hydroxycarbonimidoyl)(hydroxyimino)methyl]phenoxy}butanoic acid

C23H24N4O9 (500.1543)

2-amino-4-{4-[({1-[carboxy(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl}-c-hydroxycarbonimidoyl)(hydroxyimino)methyl]phenoxy}butanoic acid

C23H24N4O9 (500.1543)

2-(3,4-dihydroxyphenyl)ethyl (1r,4as,9s,9as)-1-hydroxy-9-[2-(4-hydroxyphenyl)ethoxy]-6-oxo-1h,4ah,5h,8h,9h,9ah-pyrano[3,4-d]oxepine-4-carboxylate

C26H28O10 (500.1682)

2-[(4-hydroxy-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}naphthalen-1-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C22H28O13 (500.153)

7-{[(2s,3r,4s,5s,6r)-6-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)-3-methyloxolan-2-yl]oxy}methyl)-3,4,5-trihydroxy-3-methyloxan-2-yl]oxy}-6-hydroxychromen-2-one

C22H28O13 (500.153)

2-(hydroxymethyl)-6-{[4'-methoxy-4-(4-methoxyphenyl)-[1,1'-biphenyl]-2,6-diyl]oxy}oxane-3,4,5-triol

C26H28O10 (500.1682)

(2s,3r,4r,5r,6s)-5-(acetyloxy)-2-[(4,5-dihydroxy-7-methyl-9,10-dioxoanthracen-2-yl)oxy]-4-hydroxy-6-methyloxan-3-yl acetate

C25H24O11 (500.1319)

(1r,2s,3e)-1-(2,4-dihydroxyphenyl)-2-(3,5-dihydroxyphenyl)-3-[(4-hydroxy-3-methoxyphenyl)methylidene]-1,2-dihydroindene-5,6-diol

C29H24O8 (500.1471)

2-(3,5-dihydroxyphenyl)-1-[ethoxy(4-hydroxyphenyl)methyl]-3-(4-hydroxyphenyl)-2,3-dihydro-1h-indene-4,6-diol

C30H28O7 (500.1835)

(2r,3r)-3,7-bis(acetyloxy)-2-[3,4-bis(acetyloxy)phenyl]-3,4-dihydro-2h-1-benzopyran-5-yl acetate

C25H24O11 (500.1319)

16,18-dimethyl (1s,2r,6r,17s,18r,19r,21s,23s)-18-hydroxy-23-methoxy-11,13,20-trioxa-3,16-diazaoctacyclo[15.6.2.0¹,¹⁹.0²,⁶.0³,²¹.0⁶,¹⁷.0⁷,¹⁵.0¹⁰,¹⁴]pentacosa-7(15),8,10(14)-triene-16,18-dicarboxylate

C25H28N2O9 (500.1795)

(8r,9s)-16-(3,4-dihydroxyphenyl)-8-(4-hydroxyphenyl)-15-oxatetracyclo[8.6.1.0²,⁷.0¹⁴,¹⁷]heptadeca-1(16),2,4,6,10(17),11,13-heptaene-3,4,6,9,12-pentol

C28H20O9 (500.1107)

11,17-dihydroxy-7,7,20,20-tetramethyl-10-(3-methylbut-2-en-1-yl)-2,8,19,25-tetraoxahexacyclo[12.11.0.0³,¹².0⁴,⁹.0¹⁵,²⁴.0¹⁸,²³]pentacosa-1(14),3,5,9,11,15(24),16,18(23),21-nonaen-13-one

C30H28O7 (500.1835)

3-(acetyloxy)-2-[(4,5-dihydroxy-7-methyl-9,10-dioxoanthracen-2-yl)oxy]-5-hydroxy-6-methyloxan-4-yl acetate

C25H24O11 (500.1319)

2-(2,4-dichloro-5-methoxy-3-methylphenoxy)-6-({[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)oxane-3,4,5-triol

C19H26Cl2O11 (500.0852)

2-[(5-hydroxy-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}naphthalen-1-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C22H28O13 (500.153)

2,6-dihydroxy-4-{[3,4,5-tris(acetyloxy)-6-[(acetyloxy)methyl]oxan-2-yl]oxy}benzoic acid

C21H24O14 (500.1166)

5-hydroxy-3-(4-hydroxyphenyl)-6-(3-methylbut-2-en-1-yl)-7-{[(2s,3s,4s,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-4-one

C26H28O10 (500.1682)

5-hydroxy-3-(4-hydroxyphenyl)-6-(3-methylbut-2-en-1-yl)-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-4-one

C26H28O10 (500.1682)

5-hydroxy-3-(4-hydroxyphenyl)-6-(3-methylbut-2-en-1-yl)-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-4-one

C26H28O10 (500.1682)

n-[2-hydroxy-1-(3,4,5-trihydroxy-6-{[2-(2-hydroxybenzoyloxy)ethyl]sulfanyl}oxan-2-yl)propyl]pyrrolidine-2-carboximidic acid

C22H32N2O9S (500.1828)

7-hydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-5-methoxy-3,4-dihydro-2h-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate

C25H24O11 (500.1319)

3,7-bis(acetyloxy)-2-[3,4-bis(acetyloxy)phenyl]-3,4-dihydro-2h-1-benzopyran-5-yl acetate

C25H24O11 (500.1319)